These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 22947651
21. Central sleep-disordered breathing and the effects of oxygen therapy in infants with Prader-Willi syndrome. Urquhart DS, Gulliver T, Williams G, Harris MA, Nyunt O, Suresh S. Arch Dis Child; 2013 Aug; 98(8):592-5. PubMed ID: 23761691 [Abstract] [Full Text] [Related]
22. Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome. Nixon GM, Rodda CP, Davey MJ. J Clin Endocrinol Metab; 2011 Jan; 96(1):29-33. PubMed ID: 20943780 [Abstract] [Full Text] [Related]
23. Sleep disordered breathing in infants with Prader-Willi syndrome during the first 6 weeks of growth hormone therapy: a pilot study. Miller JL, Shuster J, Theriaque D, Driscoll DJ, Wagner M. J Clin Sleep Med; 2009 Oct 15; 5(5):448-53. PubMed ID: 19961030 [Abstract] [Full Text] [Related]
24. What is the value of growth hormone therapy in Prader Willi syndrome? Bridges N. Arch Dis Child; 2014 Feb 15; 99(2):166-70. PubMed ID: 24162007 [Abstract] [Full Text] [Related]
25. Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Frystyk J, Christiansen JS, Höybye C. Growth Horm IGF Res; 2011 Aug 15; 21(4):185-90. PubMed ID: 21664161 [Abstract] [Full Text] [Related]
26. Polysomnographic characteristics in patients with Prader-Willi syndrome. Lin HY, Lin SP, Lin CC, Tsai LP, Chen MR, Chuang CK, Huang CY. Pediatr Pulmonol; 2007 Oct 15; 42(10):881-7. PubMed ID: 17722117 [Abstract] [Full Text] [Related]
27. The effect of growth hormone on sleep-related cardio-respiratory control in Prader-Willi syndrome. Katz-Salamon M, Lindgren AC, Cohen G. Acta Paediatr; 2012 Jun 15; 101(6):643-8. PubMed ID: 22385467 [Abstract] [Full Text] [Related]
29. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. Festen DA, Visser TJ, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC. Clin Endocrinol (Oxf); 2007 Sep 15; 67(3):449-56. PubMed ID: 17716335 [Abstract] [Full Text] [Related]
30. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome. Cohen M, Harrington J, Narang I, Hamilton J. Clin Endocrinol (Oxf); 2015 Aug 15; 83(2):212-5. PubMed ID: 25495188 [Abstract] [Full Text] [Related]
31. Prevalence of Sleep-Disordered Breathing in Prader-Willi Syndrome. Abushahin A, Al-Naimi A, Abu-Hasan M, Arar R, Lina Hayati M, Belavendra A, Janahi IA. Can Respir J; 2023 Aug 15; 2023():9992668. PubMed ID: 37927914 [Abstract] [Full Text] [Related]
32. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis. Scheermeyer E, Hughes I, Harris M, Ambler G, Crock P, Verge CF, Craig ME, Bergman P, Werther G, van Driel M, Davies PS, Choong CS. J Paediatr Child Health; 2013 Dec 15; 49(12):1045-51. PubMed ID: 23781979 [Abstract] [Full Text] [Related]
33. Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy, and body composition. Williams K, Scheimann A, Sutton V, Hayslett E, Glaze DG. J Clin Sleep Med; 2008 Apr 15; 4(2):111-8. PubMed ID: 18468308 [Abstract] [Full Text] [Related]
34. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome. Bakker NE, van Doorn J, Renes JS, Donker GH, Hokken-Koelega AC. J Clin Endocrinol Metab; 2015 Aug 15; 100(8):3041-9. PubMed ID: 26050733 [Abstract] [Full Text] [Related]
35. Psychomotor development in infants with Prader-Willi syndrome and associations with sleep-related breathing disorders. Festen DA, Wevers M, de Weerd AW, van den Bossche RA, Duivenvoorden HJ, Otten BJ, Wit JM, Hokken-Koelega AC. Pediatr Res; 2007 Aug 15; 62(2):221-4. PubMed ID: 17597659 [Abstract] [Full Text] [Related]
36. The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences. Marostica E, Grugni G, De Nicolao G, Marazzi N, Crinò A, Cappa M, Sartorio A. Growth Horm IGF Res; 2013 Dec 15; 23(6):261-6. PubMed ID: 24090687 [Abstract] [Full Text] [Related]
37. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome. Höybye C, Thorén M, Böhm B. J Intellect Disabil Res; 2005 Apr 15; 49(Pt 4):245-52. PubMed ID: 15816811 [Abstract] [Full Text] [Related]
38. Effects of growth hormone therapy on cardiac dimensions in children and adolescents with Prader-Willi syndrome. Hauffa BP, Knaup K, Lehmann N, Neudorf U, Nagel B. Horm Res Paediatr; 2011 Apr 15; 75(1):56-62. PubMed ID: 20924154 [Abstract] [Full Text] [Related]
39. Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome. Eiholzer U, L'allemand D, Schlumpf M, Rousson V, Gasser T, Fusch C. J Pediatr; 2004 Jun 15; 144(6):753-8. PubMed ID: 15192622 [Abstract] [Full Text] [Related]
40. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome. Crinò A, Di Giorgio G, Manco M, Grugni G, Maggioni A. Horm Res; 2007 Jun 15; 68(2):83-90. PubMed ID: 17337902 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]